ClinicalTrials.Veeva

Menu

Needle-Free Monitoring for IVF Patient Cycles

B

Boston IVF

Status

Unknown

Conditions

Infertility

Study type

Observational

Funder types

Other

Identifiers

NCT03162809
SAL201702

Details and patient eligibility

About

Salivary diagnostic testing is emerging as a less invasive, inexpensive alternative to serum analyte measurements with proven diagnostic accuracy in clinical settings. This study aims to continue analyzing aspects of the performance of salivary hormone competitive immunoassays for monitoring patient's reproductive hormone profiles in the reproductive cycle. Hormone levels will be monitored during treatment cycles for infertility.

Full description

This study will be a prospective study to measure salivary and serum estrogen and progesterone levels in subject's voluntarily undergoing monitored infertility treatment cycles including controlled ovarian stimulation (COS) with oral agents or gonadotropins and controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF). Ultimately, the potential applicability and reliability of salivary steroid monitoring in IVF cycles will be assessed.

Enrollment

300 estimated patients

Sex

Female

Ages

25 to 43 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosis of infertility.
  • Cycle start age of 25 -43 years.
  • Undergoing controlled ovarian stimulation for IVF.
  • All monitoring scheduled at the participating IVF facility.

Exclusion criteria

-Prior cancelled cycle due to hyperstimulation.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems